Epithelial–mesenchymal transition is driven by transcriptional and post transcriptional modulations in COPD: implications for disease progression and new therapeutics

References

• WHO. World Health. Organisation, chronic obstructive pulmonary disease (COPD)- key facts. 2016 Available from: http://wwwwhoint/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
   Google Scholar
• Lee JJ, Liu D, Lee JS, et al. Long-term impact of smoking on lung epithelial proliferation in current and former smokers. J Natl Cancer Inst. 2001;93(14):1081–1088. doi:10.1093/jnci/93.14.108111459869
   PubMedGoogle Scholar
• Eapen MS, Myers S, Walters EH, Sohal SS. Airway inflammation in chronic obstructive pulmonary disease (COPD): a true paradox. Expert Rev Respir Med. 2017;11(10):827–839. doi:10.1080/17476348.2017.136076928743228
   PubMed Web of Science ®Google Scholar
• Peters EJ, Morice R, Benner SE, et al. Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest. 1993;103(5):1429–1432. doi:10.1378/chest.103.5.14298486022
   PubMed Web of Science ®Google Scholar
• Ojo O, Lagan AL, Rajendran V, et al. Pathological changes in the COPD lung mesenchyme - Novel lessons learned from in vitro and in vivo studies. Pulm Pharmacol Ther. 2014. doi:10.1016/j.pupt.2014.04.004
   Web of Science ®Google Scholar
• Makita H, Nasuhara Y, Nagai K, et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax. 2007;62(11):932–937. doi:10.1136/thx.2006.07277717573447
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152(5 Pt 2):S77–S121.7582322
   PubMed Web of Science ®Google Scholar
• Koo HK, Vasilescu DM, Booth S, et al. Small airways disease in mild and moderate chronic obstructive pulmonary disease: a cross-sectional study. Lancet Respir Med. 2018;6(8):591–602.30072106
   PubMed Web of Science ®Google Scholar
• Kirby M, Tanabe N, Tan WC, et al. Total airway count on computed tomography and the risk of chronic obstructive pulmonary disease progression. findings from a population-based study. Am J Respir Crit Care Med. 2018;197(1):56–65.28886252
   PubMed Web of Science ®Google Scholar
• Hallstrand TS, Hackett TL, Altemeier WA, Matute-Bello G, Hansbro PM, Knight DA. Airway epithelial regulation of pulmonary immune homeostasis and inflammation. Clin Immunol (orlando, Fla). 2014;151(1):1–15. doi:10.1016/j.clim.2013.12.003
   PubMed Web of Science ®Google Scholar
• Moheimani F, Roth HM, Cross J, et al. Disruption of beta-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair. Int J Biochem Cell Biol. 2015;68:59–69. doi:10.1016/j.biocel.2015.08.01426315281
   PubMed Web of Science ®Google Scholar
• Puchelle E, Zahm JM, Tournier JM, Coraux C. Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3(8):726–733. doi:10.1513/pats.200605-126SF17065381
   PubMedGoogle Scholar
• Aghapour M, Raee P, Moghaddam SJ, Hiemstra PS, Heijink IH. Airway epithelial barrier dysfunction in chronic obstructive pulmonary disease: role of cigarette smoke exposure. Am J Respir Cell Mol Biol. 2018;58(2):157–169. doi:10.1165/rcmb.2017-0200TR28933915
   PubMed Web of Science ®Google Scholar
• Shaykhiev R, Crystal RG. Early events in the pathogenesis of chronic obstructive pulmonary disease. smoking-induced reprogramming of airway epithelial basal progenitor cells. Ann Am Thorac Soc. 2014;11(Suppl 5):S252–S258. doi:10.1513/AnnalsATS.201402-049AW25525728
   PubMedGoogle Scholar
• Shaykhiev R, Otaki F, Bonsu P, et al. Cigarette smoking reprograms apical junctional complex molecular architecture in the human airway epithelium in vivo. Cell Mol Life Sci. 2011;68(5):877–892. doi:10.1007/s00018-010-0500-x20820852
   PubMed Web of Science ®Google Scholar
• Sohal SS. Airway basal cell reprogramming and EMT: potential key to understanding early COPD. Am J Respir Crit Care Med. 2018;197:1644–1645. doi:10.1164/rccm.201712-2450LE29385350
   PubMed Web of Science ®Google Scholar
• Nowrin K, Sohal SS, Peterson G, Patel R, Walters EH. Epithelial-mesenchymal transition as a fundamental underlying pathogenic process in COPD airways: fibrosis, remodeling and cancer. Expert Rev Respir Med. 2014;8(5):547–559. doi:10.1586/17476348.2014.94885325113142
   PubMed Web of Science ®Google Scholar
• Sohal SS. Endothelial to mesenchymal transition (EndMT): an active process in Chronic Obstructive Pulmonary Disease (COPD)? Respir Res. 2016;17(1):20. doi:10.1186/s12931-016-0337-426898357
   PubMed Web of Science ®Google Scholar
• Königshoff M. Lung cancer in pulmonary fibrosis: tales of epithelial cell plasticity. Respiration. 2011;81(5):353–358. doi:10.1159/00032629921502777
   PubMed Web of Science ®Google Scholar
• Kumar JM, Chris W, Suji EM, et al. Epithelial–mesenchymal transition, a spectrum of states: role in lung development, homeostasis, and disease. Develop Dyn. 2018;247(3):346–358. doi:10.1002/dvdy.24541
   Web of Science ®Google Scholar
• Gurzu S, Turdean S, Kovecsi A, Contac AO, Jung I. Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: an update. World J Clin Cases. 2015;3:393. doi:10.12998/wjcc.v3.i5.39325984514
   PubMed Web of Science ®Google Scholar
• Sohal SS, Walters EH. Advanced non-small-cell lung cancer. N Engl J Med. 2017;377(20):1998–1999. doi:10.1056/NEJMc1712794
   PubMed Web of Science ®Google Scholar
• Milara J, Peiró T, Serrano A, Cortijo J. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax. 2013;68(5):410–420. doi:10.1136/thoraxjnl-2012-20176123299965
   PubMed Web of Science ®Google Scholar
• Sohal SS, Reid D, Soltani A, et al. Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease. Respir Res. 2011;12. doi:10.1186/1465-9921-12-130
   Google Scholar
• Sohal SS, Walters EH. Epithelial mesenchymal transition (EMT) in small airways of COPD patients. Thorax. 2013;68:783–784. doi:10.1136/thoraxjnl-2013-20337323492370
   PubMed Web of Science ®Google Scholar
• Mahmood MQ, Sohal SS, Shukla SD, et al. Epithelial mesenchymal transition in smokers: large versus small airways and relation to airflow obstruction. Int J Chron Obstruct Pulmon Dis. 2015;10:1515–1524.26346976
   PubMed Web of Science ®Google Scholar
• Sohal SS. Chronic obstructive pulmonary disease (COPD) and lung cancer: epithelial mesenchymal transition (EMT), the missing link? EBioMedicine. 2015;2:1578–1579. doi:10.1016/j.ebiom.2015.10.01626870773
   PubMed Web of Science ®Google Scholar
• Sohal S, Reid D, Soltani A, et al. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology. 2010;15(6):930–938. doi:10.1111/j.1440-1843.2010.01808.x20630030
   PubMed Web of Science ®Google Scholar
• Schneider M, Hansen JL, Sheikh SP. S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?. J Mol Med. 2008;86:507–522. doi:10.1007/s00109-007-0301-318322670
   PubMed Web of Science ®Google Scholar
• Sohal SS, Soltani A, Weston S, Wood-Baker R, Walters H. Intermediate filament vimentin and potential role in epithelial mesenchymal transition (EMT). Vimentin Concepts Mol Mech. 2013.
   Google Scholar
• Sohal SS, Reid D, Soltani A, et al. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology. 2010;15:930–938. doi:10.1111/j.1440-1843.2010.01808.x20630030
   PubMed Web of Science ®Google Scholar
• Soltani A, Walters EH, Reid DW, et al. Inhaled corticosteroid normalizes some but not all airway vascular remodeling in COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:2359–2367. doi:10.2147/COPD.S11317627703346
   PubMed Web of Science ®Google Scholar
• Sohal SS, Reid D, Soltani A, Ward C, Weston S, Muller HK. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology. 2010;15:930–938.20630030
   PubMed Web of Science ®Google Scholar
• Soltani A, Reid DW, Sohal SS, et al. Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study. Respir Res. 2010;11(1):105. doi:10.1186/1465-9921-11-6220670454
   PubMed Web of Science ®Google Scholar
• Sohal SS, Soltani A, Reid D, et al. A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial-mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study. Int J Chron Obstruct Pulmon Dis. 2014;9. doi:10.2147/COPD.S60179
   Web of Science ®Google Scholar
• Sohal SS, Mahmood QM, Walters HE. Clinical significance of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD): potential target for prevention of airway fibrosis and lung cancer. Clin Transl Med. 2014;3. doi:10.1186/s40169-014-0033-2
   Google Scholar
• Raymakers AJ, McCormick N, Marra CA, Fitzgerald JM, Sin D, Lynd LD. Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic review. Respirology. 2017;22(1):61–70. doi:10.1111/resp.1291927761973
   PubMed Web of Science ®Google Scholar
• Milara J, Peiro T, Serrano A, et al. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD. Pulm Pharmacol Ther. 2014;28(2):138–148. doi:10.1016/j.pupt.2014.02.00124525294
   PubMed Web of Science ®Google Scholar
• Gohy ST, Hupin C, Fregimilicka C, et al. Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition. Eur Respir J. 2015. doi:10.1183/09031936.00135814
   Web of Science ®Google Scholar
• Wang Q, Wang Y, Zhang Y, Zhang Y, Xiao W. The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease. Respir Res. 2013;14(1):67. doi:10.1186/1465-9921-14-1923806081
   PubMed Web of Science ®Google Scholar
• Froidure A, Ladjemi MZ, Pilette C. Interleukin-1α: a key player for epithelial-to-mesenchymal signalling in COPD? Eur Respir J. 2016;48(2):301–304. doi:10.1183/13993003.01180-201627478185
   PubMed Web of Science ®Google Scholar
• Osei ET, Noordhoek JA, Hackett TL, et al. Interleukin-1alpha drives the dysfunctional cross-talk of the airway epithelium and lung fibroblasts in COPD. Eur Respir J. 2016;48(2):359–369. doi:10.1183/13993003.01911-201527418555
   PubMed Web of Science ®Google Scholar
• Soltani A, Sohal S, Reid D, Weston S, Wood-Baker R, Walters E. Vessel-associated transforming growth factor-Beta1 (TGF-beta1) is increased in the bronchial reticular basement membrane in COPD and normal smokers. PLoS One. 2012;7(6):e39736. doi:10.1371/journal.pone.003973622768115
   PubMed Web of Science ®Google Scholar
• Mahmood MQ, Reid D, Ward C, et al. Transforming growth factor (TGF) beta1 and Smad signalling pathways: a likely key to EMT-associated COPD pathogenesis. Respirology. 2017;22(1):133–140. doi:10.1111/resp.1288227614607
   PubMed Web of Science ®Google Scholar
• Springer J, Scholz FR, Peiser C, Groneberg DA, Fischer A. SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke. Biol Chem. 2004;385(7):649–653. doi:10.1515/BC.2004.08015318814
   PubMed Web of Science ®Google Scholar
• Zandvoort A, Postma DS, Jonker MR, et al. Altered expression of the Smad signalling pathway: implications for COPD pathogenesis. Eur Respir J. 2006;28(3):533–541. doi:10.1183/09031936.06.0007840516707515
   PubMed Web of Science ®Google Scholar
• Verhamme FM, Bracke KR, Joos GF, Brusselle GG. Transforming growth factor-β superfamily in obstructive lung diseases. more suspects than TGF-β alone. Am J Respir Cell Mol Biol. 2015;52(6):653–662. doi:10.1165/rcmb.2014-0282RT25396302
   PubMed Web of Science ®Google Scholar
• Mahmood MQ, Walters EH, Shukla SD, et al. β-catenin, twist and snail: transcriptional regulation of EMT in smokers and COPD, and relation to airflow obstruction. Sci Rep. 2017;7(1):10832. doi:10.1038/s41598-017-11375-x28883453
   PubMed Web of Science ®Google Scholar
• Zou W, Zou Y, Zhao Z, Li B, Ran P. Nicotine-induced epithelial-mesenchymal transition via Wnt/beta-catenin signaling in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2013;304(4):L199–L209. doi:10.1152/ajplung.00094.201223204070
   PubMed Web of Science ®Google Scholar
• Kneidinger N, AÖ Y, Callegari J, et al. Activation of the WNT/β-catenin pathway attenuates experimental emphysema. Am J Respir Crit Care Med. 2011;183(6):723–733. doi:10.1164/rccm.200910-1560OC20889911
   PubMed Web of Science ®Google Scholar
• Skronska-Wasek W, Mutze K, Baarsma HA, et al. Reduced frizzled receptor 4 expression prevents WNT/β-catenin–driven alveolar lung repair in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;196(2):172–185. doi:10.1164/rccm.201605-0904OC28245136
   PubMed Web of Science ®Google Scholar
• Baarsma HA, Königshoff M. ‘WNT-er is coming’: WNT signalling in chronic lung diseases. Thorax. 2017;72(8):746–759. doi:10.1136/thoraxjnl-2016-20975328416592
   PubMed Web of Science ®Google Scholar
• Heijink IH, de Bruin HG, Dennebos R, et al. Cigarette smoke-induced epithelial expression of WNT-5B: implications for COPD. Eur Respir J. 2016;48(2):504–515. doi:10.1183/13993003.01541-201527126693
   PubMed Web of Science ®Google Scholar
• DiRenzo DM, Chaudhary MA, Shi X, et al. A crosstalk between TGF-β/Smad3 and Wnt/β-catenin pathways promotes vascular smooth muscle cell proliferation. Cell Signal. 2016;28(5):498–505. doi:10.1007/s12032-017-0900-y26912210
   PubMed Web of Science ®Google Scholar
• Zhou B, Liu Y, Kahn M, et al. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). J Biol Chem. 2012;287(10):7026–7038. doi:10.1074/jbc.M111.27631122241478
   PubMed Web of Science ®Google Scholar
• Jiang B, Guan Y, Shen H-J, et al. Akt/PKB signaling regulates cigarette smoke-induced pulmonary epithelial-mesenchymal transition. Lung Cancer. 2018;122:44–53. doi:10.1016/j.lungcan.2018.05.01930032844
   PubMed Web of Science ®Google Scholar
• Lai T, Li Y, Chen M, et al. Heparin-binding epidermal growth factor contributes to COPD disease severity by modulating airway fibrosis and pulmonary epithelial-mesenchymal transition. Lab Invest. 2018;98(9):1159–1169. doi:10.1038/s41374-018-0049-029581578
   PubMed Web of Science ®Google Scholar
• Eapen MS, Sharma P, Thompson IE, et al. Heparin-binding epidermal growth factor (HB-EGF) drives EMT in patients with COPD: implications for disease pathogenesis and novel therapies. Lab Invest. 2019;99(2):150–157. doi:10.1038/s41374-018-0146-030451982
   PubMed Web of Science ®Google Scholar
• Sun J, Gu X, Wu N, Zhang P, Liu Y, Jiang S. Human antigen R enhances the epithelial-mesenchymal transition via regulation of ZEB-1 in the human airway epithelium. Respir Res. 2018;19. doi:10.1186/s12931-018-0805-0
   Web of Science ®Google Scholar
• Zhou Y, Chang R, Ji W, et al. Loss of scribble promotes snail translation through translocation of HuR and enhances cancer drug resistance. J Biol Chem. 2016;291(1):291–302. doi:10.1074/jbc.M115.69385326527679
   PubMed Web of Science ®Google Scholar
• Gu XM, Wang XG, Sun J, Wang N, Jiang SJ. The role of HuR in mediating snail expression in human small airway epithelium induced by cigarette smoke extract. Zhonghua Jie He He Hu Xi Za Zhi. 2017;40(7):515–519. doi:10.3760/cma.j.issn.1001-0939.2017.07.00828728276
   PubMedGoogle Scholar
• Kim I, Hur J, Jeong S. HuR represses Wnt/β-catenin-mediated transcriptional activity by promoting cytoplasmic localization of β-catenin. Biochem Biophys Res Commun. 2015;457(1):65–70. doi:10.1016/j.bbrc.2014.12.05225534855
   PubMed Web of Science ®Google Scholar
• Sohal SS, Hansbro PM, Walters EH. Epithelial mesenchymal transition in chronic obstructive pulmonary disease, a precursor for epithelial cancers: understanding and translation to early therapy. Ann Am Thorac Soc. 2017;14(9):1491–1492. doi:10.1513/AnnalsATS.201705-387LE28594567
   PubMed Web of Science ®Google Scholar
• Sohal SS. Chronic Obstructive Pulmonary Disease (COPD) and lung cancer: epithelial mesenchymal transition (EMT), the missing link? EBioMedicine. 2015;2(11):1578–1579. doi:10.1016/j.ebiom.2015.10.01626870773
   PubMed Web of Science ®Google Scholar
• Mahmood MQ, Ward C, Muller HK, Sohal SS, Walters EH. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease. Med Oncol. 2017;34(3):45.28197929
   PubMed Web of Science ®Google Scholar
• Sohal SS, Eapen MS, Ward C, Walters EH. Epithelial mesenchymal transition (EMT): a necessary new therapeutic target in COPD? Am J Respir Crit Care Med. 2017. doi:10.1164/rccm.201704-0771LE
   Web of Science ®Google Scholar
• Andersson-Sjöland A, Nihlberg K, Eriksson L, Bjermer L, Westergren-Thorsson G. Fibrocytes and the tissue niche in lung repair. Respir Res. 2011;12(1):76. doi:10.1186/1465-9921-12-12221658209
   PubMed Web of Science ®Google Scholar
• Sohal SS. Epithelial and endothelial cell plasticity in chronic obstructive pulmonary disease (COPD). Respir Investig. 2017;55(2):104–113.
   PubMed Web of Science ®Google Scholar
• Eapen MS, Myers S, Lu W, Tanghe C, Sharma P, Sohal SS. sE-cadherin and sVE-cadherin indicate active epithelial/endothelial to mesenchymal transition (EMT and EndoMT) in smokers and COPD: implications for new biomarkers and therapeutics. Biomarkers. 2018;23:1–5.29144175
   PubMed Web of Science ®Google Scholar
• Burgess JK, Mauad T, Tjin G, Karlsson JC, Westergren‐Thorsson G. The extracellular matrix – the under‐recognized element in lung disease? J Pathol. 2016;240(4):397–409.27623753
   PubMed Web of Science ®Google Scholar
• Baarsma HA, Spanjer AIR, Haitsma G, et al. Activation of WNT/β-catenin signaling in pulmonary fibroblasts by TGF-β1 is increased in chronic obstructive pulmonary disease. PLoS One. 2011;6(9):e25450.21980461
   PubMed Web of Science ®Google Scholar
• Akhmetshina A, Palumbo K, Dees C, et al. Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat Commun. 2012;3:735.22415826
   PubMed Web of Science ®Google Scholar
• Al-Habeeb FF, Nair PK, Azuelos I, Baglole C. The role of HuR in myofibroblast differentiation: implication for pulmonary fibrosis. A68 molecular determinants of remodeling in lung fibrosis. Am Thorac Soc Int Conf Abstr. 2018;197:A2205–A.
   Google Scholar
• Eapen MS, Sohal SS. Understanding novel mechanisms of microbial pathogenesis in chronic lung disease: implications for new therapeutic targets. Clin Sci (Lond). 2018;132(3):375–379.29439118
   PubMed Web of Science ®Google Scholar
• Sohal SS. Inhaled corticosteroids and increased microbial load in COPD: potential role of epithelial adhesion molecules. Eur Respir J. 2018;51(2):1702257.29386338
   PubMed Web of Science ®Google Scholar
• Sohal SS, Eapen MS, Ward C, Walters EH. Airway inflammation and inhaled corticosteroids in COPD. Eur Respir J. 2017;49(6):1700289.28619960
   PubMed Web of Science ®Google Scholar
• Eapen MS, McAlinden K, Tan D, et al. Profiling cellular and inflammatory changes in the airway wall of mild to moderate COPD. Respirology. 2017;22(6):1125–1132.28326668
   PubMed Web of Science ®Google Scholar
• Eapen MS, Hansbro PM, McAlinden K, et al. Abnormal M1/M2 macrophage phenotype profiles in the small airway wall and lumen in smokers and chronic obstructive pulmonary disease (COPD). Sci Rep. 2017;7(1):13392.29042607
   PubMed Web of Science ®Google Scholar
• Zhu L, Fu X, Chen X, Han X, Dong P. M2 macrophages induce EMT through the TGF-beta/Smad2 signaling pathway. Cell Biol Int. 2017;41(9):960–968.28493530
   PubMed Web of Science ®Google Scholar
• Yu CC, Chien CT, Chang TC. M2 macrophage polarization modulates epithelial-mesenchymal transition in cisplatin-induced tubulointerstitial fibrosis. BioMedicine. 2016;6(1):5.26872813
   PubMedGoogle Scholar
• Braga TT, Agudelo JSH, Camara NOS. Macrophages during the fibrotic process: M2 as friend and foe. Front Immunol. 2015;6:602.26635814
   PubMed Web of Science ®Google Scholar
• Eapen MS, Sharma P, Moodley YP, Hansbro PM, Sohal SS. Dysfunctional immunity and microbial adhesion molecules in smoking-induced pneumonia. Am J Respir Crit Care Med. 2018;199:250–251.
   Web of Science ®Google Scholar
• Jubrail J, Kurian N, Niedergang F. Macrophage phagocytosis cracking the defect code in COPD. Biomed J. 2017;40(6):305–312.29433833
   PubMed Web of Science ®Google Scholar
• McKendry RT, Spalluto CM, Burke H, et al. Dysregulation of antiviral function of CD8(+) T cells in the chronic obstructive pulmonary disease lung. role of the PD-1-PD-L1 axis. Am J Respir Crit Care Med. 2016;193(6):642–651.26517304
   PubMed Web of Science ®Google Scholar
• Yiakouvaki A, Dimitriou M, Karakasiliotis I, Eftychi C, Theocharis S, Kontoyiannis DL. Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesis. J Clin Invest. 2012;122(1):48–61.22201685
   PubMed Web of Science ®Google Scholar
• Katsanou V, Papadaki O, Milatos S, et al. HuR as a negative posttranscriptional modulator in inflammation. Mol Cell. 2005;19(6):777–789.16168373
   PubMed Web of Science ®Google Scholar
• Eapen MS, Hansbro PM, Larsson-Callerfelt AK, et al. Chronic obstructive pulmonary disease and lung cancer: underlying pathophysiology and new therapeutic modalities. Drugs. 2018;78(16):1717–1740.30392114
   PubMed Web of Science ®Google Scholar
• Sohal SS, Walters EH. Essential need for rethink of COPD airway pathology: implications for new drug approaches for prevention of lung cancer as well as small airway fibrosis. Int J Chron Obstruct Pulmon Dis. 2017;12:2677–2679.28919735
   PubMed Web of Science ®Google Scholar